While she followed breast cancer screening guidelines and went in yearly for her mammogram, Nancy Cappello was diagnosed with late-stage breast cancer due to it being missed on standard mammography. Why? Because she had dense breasts. Following her diagnosis, she and her husband, Joe Cappello, made it their mission to change the standard of care for dense breast cancer screening. Unfortunately, Nancy passed away a few years ago following treatment for breast cancer, but her husband still works tirelessly advocating for legislation and new breast cancer screening technologies that work for women with dense breasts.

Hear from the venture capital investors on why they chose to invest in Delphinus and what factors they consider when determining what companies to invest in.

This episode features the research coordinators who assisted with recruiting women to participate in the SoftVue prospective case collection that provided the evidence for FDA approval of SoftVue as a supplemental screening option for women with dense breasts. They touch on the experience of the women who participated at their health care facilities.

With SoftVue's origins traced back to the Barbara Ann Karmanos Cancer Institute, it is only fitting they are the first site to clinically adopt SoftVue to address the dense breast imaging challenge in their breast center. Mark J. Forchette speaks with Dr. Natasha Robinette, Clinical Service Chief of Imaging at Karmanos Cancer Institute about their decision to add SoftVue to their center and how it is being received by patients, the team of doctors, technicians and support staff.

Hear from Dr. Mary Yamahsita on why she dedicated her time to lead the prospective case collection to determine SoftVue's clinical benefit for detecting breast cancer in women with dense breasts.

This episode features the innovators behind SoftVue 3D Whole Breast Ultrasound Tomography and why they were dedicated to developing and advancing the next generation of breast imaging technology.

This episode provides the background of the problem that SoftVue 3D Whole Breast Ultrasound Tomography was developed to address.